{
    "id": "dbpedia_8465_0",
    "rank": 85,
    "data": {
        "url": "https://www.drugs.com/international/minoxidil.html",
        "read_more_link": "",
        "language": "en",
        "title": "Minoxidil (International database)",
        "top_image": "https://www.drugs.com/img/social/ddc-opengraph-logomark.png",
        "meta_img": "https://www.drugs.com/img/social/ddc-opengraph-logomark.png",
        "images": [
            "https://www.drugs.com/img/logo/drugscom-logo.svg",
            "https://www.drugs.com/img/v-20240725/apps/apple-store.png",
            "https://www.drugs.com/img/v-20240725/apps/google-play.png",
            "https://www.drugs.com/img/v-20240725/apps/promo-uberapp.png",
            "https://www.drugs.com/img/logo/drugscom-logo-mark.svg",
            "https://privacy-policy.truste.com/privacy-seal/seal?rid=d18cba4a-afc4-4863-af81-8262bb120271",
            "https://www.drugs.com/img/v-20240725/logo/vendor/tag-verified.png",
            "https://www.drugs.com/img/v-20240725/logo/vendor/trust-mark-logo.png",
            "https://www.drugs.com/img/v-20240725/logo/vendor/adchoices-logomark.png"
        ],
        "movies": [],
        "keywords": [],
        "meta_keywords": [
            ""
        ],
        "tags": null,
        "authors": [
            "www.facebook.com"
        ],
        "publish_date": null,
        "summary": "",
        "meta_description": "Minoxidil is a medicine available in a number of countries worldwide. A list of US medications equivalent to Minoxidil is available on the Drugs.com website.",
        "meta_lang": "en",
        "meta_favicon": "/img/logo/favicon/ddc-icon-32x32.png",
        "meta_site_name": "Drugs.com",
        "canonical_link": "https://www.drugs.com/international/minoxidil.html",
        "text": "Minoxidil (International)\n\nIn the US, Minoxidil (minoxidil systemic) is a member of the drug class vasodilators and is used to treat High Blood Pressure.\n\nUS matches:\n\nMinoxidil\n\nMinoxidil topical\n\nMinoxidil (Oral)\n\nMinoxidil (Topical)\n\nMinoxidil (Systemic)\n\nMinoxidil Topical Foam\n\nMinoxidil Topical Solution\n\nScheme\n\nRec.INN\n\nATC (Anatomical Therapeutic Chemical Classification)\n\nC02DC01,D11AX01\n\nCAS registry number (Chemical Abstracts Service)\n\n0038304-91-5\n\nChemical Formula\n\nC9-H15-N5-O\n\nMolecular Weight\n\n209\n\nTherapeutic Categories\n\nAntihypertensive agent\n\nVasodilator\n\nTopical treatment of androgenetic alopecia\n\nChemical Names\n\n2,4-Diamino-6-piperidinopyrimidine 3-oxide (WHO)\n\n2,4-Pyrimidinediamine, 6-(1-piperidinyl)-, 3-oxide\n\n2,6-Diamino-4-piperidinopyrimidin-1-oxid (IUPAC)\n\nForeign Names\n\nMinoxidilum (Latin)\n\nMinoxidil (German)\n\nMinoxidil (French)\n\nMinoxidil (Spanish)\n\nGeneric Names\n\nMinoxidil (OS: BAN, DCIT, DCF, USAN, JAN)\n\nU 10858 (Upjohn) (IS)\n\nMinoxidil (PH: BP 2018, Ph. Eur. 9, USP 41)\n\nMinoxidilum (PH: Ph. Eur. 9)\n\nBrand Names\n\nAdhair [+ Amifampridine]\n\nUnichem, India\n\nAga\n\nNidus, India\n\nAlerana\n\nVertex, Russian Federation\n\nAlocutan\n\nSun-Farm, Poland\n\nAlocutan 20 mg/ml\n\nDermapharm, Austria\n\nAlocutan 50 mg/ml\n\nDermapharm, Austria\n\nAlocutan Forte\n\nSun-Farm, Poland\n\nAlomax\n\nBelupo, Croatia (Hrvatska); Belupo, Macedonia\n\nAlomax 5%\n\nBelupo, Serbia\n\nAlopek\n\nRoyal Pharma, Chile\n\nAlopexy\n\nPierre Fabre, Romania; Pierre Fabre, Russian Federation; Pierre Fabre Hellas AE, Greece; Pierre Fabre Iberica, Spain; Pierre Fabre, Poland; Pierre Fabre, Tunisia\n\nAlopexy 2%\n\nPierre Fabre, Switzerland; Pierre Fabre, Luxembourg; Pierre Fabre Dermatologie, France; Pierre Fabre Sante, Belgium\n\nAlopexy 5%\n\nPierre Fabre, Austria; Pierre Fabre, Luxembourg; Pierre Fabre, Turkey; Pierre Fabre Dermatologie, France; Pierre Fabre Pharma, Germany\n\nAlorexyl\n\nPierre Fabre, Portugal\n\nAlostil 2%\n\nJohnson & Johnson, France\n\nAlostil 5%\n\nJohnson & Johnson, France\n\nAloxid\n\nInterbat, Indonesia\n\nAloxidil\n\nIDI Farmaceutici, Italy; Theraskin, Brazil; Vinas, Spain\n\nAnagen 5%\n\nCassara, Argentina; D & M Pharma, Chile\n\nAndrovium 2%\n\nAssos, Turkey\n\nAndrovium 5%\n\nAssos, Turkey\n\nAndroxil 2%\n\nLaboratoires Bailleul International SA, Greece\n\nAndroxil 5%\n\nLaboratoires Bailleul International SA, Greece\n\nApo-Gain\n\nApotex, Canada\n\nAxelan\n\nPharmazac SA, Greece\n\nAxelan 5%\n\nPharmazac SA, Greece\n\nBelohair\n\nBelupo, Czech Republic\n\nBioxinin Forte\n\nBiota, Turkey\n\nBoots Hair Loss Treatment\n\nThe Boots Company, United Kingdom\n\nBotafex\n\nPharmex, Greece\n\nBotafex 2%\n\nPharmex, Greece\n\nBotafex 5%\n\nPharmex, Greece\n\nCapillus\n\nDong-A, South Korea\n\nCapixidil\n\nDispert, Uruguay\n\nCapixidil Plus [+ Biotin, + Dexpanthenol]\n\nDispert, Uruguay\n\nCapixidil Plus Forte [+ Biotin, + Dexpanthenol]\n\nDispert, Uruguay\n\nCarexidil\n\nDifa Cooper, Italy\n\nCoverit\n\nMicro Gratia, India\n\nDa Fei Xin\n\nAnte Bio-Pharmaceutical, China\n\nDinaxil\n\nSerra Pamies, Spain\n\nEminox\n\nPharmacore Laboratories, Indonesia\n\nFolcare\n\nIFC Skincare Portugal, Portugal\n\nFolcress\n\nGrisi Hnos, Mexico\n\nFolister [+ Tretinoin]\n\nProcaps, Colombia\n\nFolister Complex [+ Tretinoin, + Clobetasol]\n\nProcaps, Colombia\n\nGainehair [+ Amifampridine]\n\nWockhardt, India\n\nGuayaten\n\nFlupal, Venezuela\n\nHair 4 U [+ Amifampridine]\n\nGlenmark, India\n\nHair A-Gain\n\nKey Pharmaceuticals, Australia\n\nHair Grow\n\nDar Al Dawa, Kuwait; Dar Al Dawa, Oman\n\nHair Max\n\nElko, Pakistan; Sante, Pakistan\n\nHair Regrowth Formula\n\nVita Health Products, Canada\n\nHairgain\n\nPerrigo, Israel\n\nHairgain 5%\n\nPerrigo, Israel\n\nHairgaine\n\nMedpharma, Oman\n\nHairgrow\n\nDar Al Dawa, Lebanon; Dar-Al-Dawa, Romania; Dar-Al-Dawa Pharm, Hong Kong\n\nHair-Treat\n\nRekah, Israel\n\nHair-Treat Forte\n\nRekah, Israel\n\nHairway\n\nBoderm, Greece\n\nHairway 5%\n\nBoderm, Greece\n\nHeadway\n\nPacific Pharm, Hong Kong\n\nHeldemax 5%\n\nInduquimica, Peru\n\nHigrow\n\nShaigan, Pakistan\n\nInoxi\n\nPsycorem, India\n\nInoxi Forte\n\nPsycorem, India\n\nKenacin\n\nCatedral, Paraguay\n\nLacovin\n\nGalderma, Spain\n\nLocemix\n\nEuroderm, Argentina\n\nLoniten\n\nIFET, Greece; Pfizer, Australia; Pfizer, Canada; Pfizer, Spain; Pfizer, United Kingdom; Pfizer, Ireland; Pfizer, New Zealand; Pfizer, Slovakia; Pfizer, Taiwan; Pfizer, South Africa; Pfizer Italia, Italy; Wyeth Pharma, Brazil\n\nLoniten 10mg\n\nPfizer PFE, Switzerland\n\nLoniten 2.5mg\n\nPfizer PFE, Switzerland\n\nLoniten 5 mg\n\nPfizer, Austria\n\nLonnoten\n\nPfizer, Netherlands\n\nLonolox 10\n\nPfizer, Germany\n\nLonolox 2,5\n\nPfizer, Germany\n\nLonoten\n\nLENIS, Slovenia; Pfizer, France; Sanolabor, Slovenia\n\nLoxon 2%\n\nSanofi-Aventis, Poland\n\nLoxon 5%\n\nSanofi-Aventis, Poland\n\nMa Evans Intervencion Capilar\n\nGenomma Laboratories México, Mexico\n\nMandi\n\nWanma Pharmaceutical, China\n\nManoxidil\n\nMarch Pharma, Thailand\n\nMen's Rogaine\n\nPfizer Consumer Healthcare, United States\n\nMinocutan\n\nMibe Pharmaceuticals, Croatia (Hrvatska)\n\nMinodil\n\nCharoon Bhesaj, Thailand\n\nMinodril\n\nBiorespond, Greece\n\nMinorax\n\nQuilab Farma, Peru\n\nMinorga\n\nBailleul, Slovakia; Laboratoires Bailleul, Malta; Laboratoires Bailleul, Romania\n\nMinostyl 2%\n\nOpalia, Tunisia\n\nMinostyl 5%\n\nOpalia, Tunisia\n\nMinox\n\nEdol, Portugal; Lafedar, Argentina\n\nMinoxi 5\n\nTrima, Israel\n\nMinoxi-5\n\nTrima Unipharm, Singapore\n\nMinoxicutan\n\nDermapharm, Germany\n\nMinoxidil\n\nBiosintética, Brazil; Labinco, Colombia; Mutual, United States; Par Pharmaceutical, United States; Perrigo, United States; Sun Pharma, United States; Target Pharma, Greece; Watson Pharmaceutical, United States\n\nMinoxidil 5%\n\nFarmindustria, Peru\n\nMinoxidil AL 2%\n\nEurofarma, Peru\n\nMinoxidil Bailleul\n\nLaboratoires Bailleul-Biorga, Hong Kong\n\nMinoxidil Bailleul 2%\n\nBailleul, France\n\nMinoxidil Bailleul 5%\n\nBailleul, France\n\nMinoxidil Bio-H-Tin Pharma\n\nDr. R. Pfleger Chemische Fabrik, Germany\n\nMinoxidil Bio-H-Tin Pharma 20mg/ml\n\nBio-H-Tin Pharma, Austria\n\nMinoxidil Bio-H-Tin Pharma 50mg/ml\n\nBio-H-Tin Pharma, Austria\n\nMinoxidil Biorga\n\nBailleul, Spain; Bailleul, Portugal\n\nMinoxidil Biorga 2%\n\nBailleul, Luxembourg; Laboratoires Bailleul, Belgium\n\nMinoxidil Biorga 5%\n\nBailleul, Luxembourg; Laboratoires Bailleul, Belgium\n\nMinoxidil Cooper 2%\n\nCooper, France\n\nMinoxidil Cooper 5%\n\nCooper, France\n\nMinoxidil Dermapharm\n\nDermapharm, United Kingdom\n\nMinoxidil extra Strength for Men\n\nActavis, United States; Perrigo, United States; Wockhardt, United States\n\nMinoxidil Fagron\n\nFagron, Netherlands\n\nMinoxidil for Men\n\nActavis, United States; Hi-Tech, United States; Perrigo, United States; Watson Pharmaceutical, United States; Wockhardt, United States\n\nMinoxidil for Women\n\nHi-Tech, United States; Perrigo, United States; Watson Pharmaceutical, United States\n\nMinoxidil Inteli\n\nInteli Generics Nord, Lithuania\n\nMinoxidil IPS\n\nIPS, Tunisia\n\nMinoxidil Isac\n\nDerm Pharma, Philippines\n\nMinoxidil Isdin\n\nIsdin, Spain\n\nMinoxidil Lab Opodex 2%\n\nLab Opodex Industries, Vietnam\n\nMinoxidil Lab Opodex 5%\n\nLab Opodex Industries, Vietnam\n\nMinoxidil Lafedar\n\nLafedar, Argentina\n\nMinoxidil Lavineli\n\nLavineli Farmaceutica, Poland\n\nMinoxidil Maxpharma\n\nMaxpharma, Latvia\n\nMinoxidil MK\n\nMK, Colombia; MK, Ecuador\n\nMinoxidil Mylan 2%\n\nMylan, France\n\nMinoxidil Mylan 5%\n\nMylan, France\n\nMinoxidil Orifarm\n\nOrifarm Generics, Sweden\n\nMinoxidil Orifarm Forte\n\nOrifarm Generics, Sweden\n\nMinoxidil Pharma Arte\n\nPharma Arte, Paraguay\n\nMinoxidil Pharmaghreb\n\nPharmaghreb, Tunisia\n\nMinoxidil Quilab Generic\n\nQuilab Farma, Peru\n\nMinoxidil Sandoz Conseil 2%\n\nSandoz, France\n\nMinoxidil Sandoz Conseil 5%\n\nSandoz, France\n\nMinoxidil Teva Conseil 2%\n\nTeva Santé, France\n\nMinoxidil Teva Conseil 5%\n\nTeva Santé, France\n\nMinoxidil Vinas\n\nVinas, Spain\n\nMinoxil\n\nDG Farma, Turkey\n\nMinoximen\n\nMenarini Industrie Farmaceutiche Riunite, Italy\n\nMinoxin\n\nBrookes, Pakistan\n\nMinoxiten\n\nSuiphar, Dominican Republic; Suiphar, Ecuador\n\nMinscalp\n\nEast West, India\n\nMintop\n\nDr. Reddy's, India\n\nModil\n\nGeneral Drugs House, Thailand\n\nMoxidil\n\nHanmi, South Korea\n\nNeocapil\n\nGalderma, Slovakia; Spirig, Czech Republic\n\nNeocapil 2%\n\nGalderma Schweiz, Switzerland\n\nNeocapil 20 mg/ml\n\nGalderma, Hungary\n\nNeocapil 5%\n\nGalderma Schweiz, Switzerland\n\nNeoxidil\n\nGalderma, Kuwait\n\nNeoxidil 2%\n\nGalderma, Lebanon; Galderma, Luxembourg; Galderma Benelux, Belgium\n\nNherea\n\nZwitter Pharmaceuticals, Greece\n\nNoxdyl Forte\n\nAbdi Ibrahim, Turkey\n\nNoxidil\n\nT.O. Chemicals, Thailand\n\nNoxidil 5%\n\nPerrigo, Israel\n\nNoxidil Forte\n\nT.O. Chemicals, Thailand\n\nOxofenil 2%\n\nCHR. K. Unimed, Cyprus\n\nPiladex\n\nTecnofarma, Paraguay\n\nPilfud\n\nBosnalijek, Bosnia & Herzegowina; Bosnalijek, Croatia (Hrvatska); Bosnalijek, Macedonia; Bosnalijek, Serbia\n\nPilogan 2%\n\nGrünenthal, Colombia\n\nPilogro\n\nFulford, India\n\nPilomin\n\nPalsons, India\n\nPiloxidil\n\nChemical Research, Poland\n\nRecrea\n\nMeda OTC, Sweden\n\nRecrea Forte\n\nMeda, Norway; Meda OTC, Sweden\n\nRegain\n\nRenata, Bangladesh\n\nRegaine\n\nAerosol-Service, Russian Federation; Janssen-Cilag, Bulgaria; Janssen-Cilag, Serbia; Johnson & Johnson, Bosnia & Herzegowina; Johnson & Johnson, Germany; Johnson & Johnson, Spain; Johnson & Johnson, Greece; Johnson & Johnson, Hong Kong; Johnson & Johnson, Croatia (Hrvatska); Johnson & Johnson, Italy; Johnson & Johnson, New Zealand; Johnson & Johnson, Portugal; Johnson & Johnson, Singapore; Johnson & Johnson, Thailand; Johnson & Johnson, Taiwan; Johnson & Johnson Consumer, Netherlands; Johnson & Johnson Pacific, Australia; McNeil, Czech Republic; McNeil, Estonia; McNeil, Ireland; McNeil, Lithuania; McNeil, Latvia; McNeil, Malta; McNeil, Oman; McNeil, Romania; McNeil Products, Slovenia; NeoFarma, Malta; Pfizer, Mexico; Pharmacia & Upjohn, Kuwait\n\nRegaine 2%\n\nJanssen-Cilag, Switzerland; Johnson & Johnson, Austria; Johnson & Johnson Hellas, Cyprus\n\nRegaine 20 mg/ml\n\nJohnson & Johnson, Hungary\n\nRegaine 5%\n\nAerosol Service, Israel; Janssen-Cilag, Switzerland; Johnson & Johnson, Austria; Johnson & Johnson, Belgium; Johnson & Johnson Hellas, Cyprus; McNeil Products, United Kingdom\n\nRegaine Extra Strength\n\nJohnson & Johnson Pacific, Australia; McNeil, Malta; McNeil Products, United Kingdom; NeoFarma, Malta\n\nRegaine Forte\n\nMcNeil, Denmark\n\nRegaxidil\n\nCantabria, Spain\n\nRegro\n\nActavis, New Zealand; DHA, Hong Kong; DHA, Malaysia; DHA, Singapore\n\nRegroe\n\nDerm Pharma, Philippines\n\nRegrou\n\nSurya Dermato Medica Lab, Indonesia\n\nRegrou Forte\n\nSurya Dermato Medica Lab, Indonesia\n\nRegrowth\n\nMedicine Products, Thailand\n\nRelive\n\nZYG, Philippines\n\nRenace-K\n\nBrisafarma, Peru\n\nRenobell\n\nLicol, Colombia\n\nReten\n\nT.O. Chemicals, Thailand\n\nRexidil\n\nWashington, Taiwan\n\nRogaine\n\nJohnson & Johnson, Canada; McNeil, Finland; McNeil, Sweden\n\nRogaine for Men\n\nJohnson & Johnson, United States\n\nRogaine for Women\n\nJohnson & Johnson, United States\n\nRogaine forte\n\nMcNeil, Sweden\n\nRogan\n\nKoçak, Turkey\n\nRoquinna\n\nMcNeil, Sweden\n\nSi Bi Shen\n\nJiqi Huakang Pharmaceutical, China\n\nSplendora\n\nSquare, Bangladesh\n\nSuperminox 2%\n\nFinadiet, Argentina\n\nSuperminox 5%\n\nFinadiet, Argentina\n\nTheroxidil\n\nEi, United States\n\nTopixidil\n\nFlupal, Venezuela\n\nTricolocion\n\nInvesti, Argentina\n\nTricolocion 5%\n\nInvesti, Argentina\n\nTricoplus\n\nRaymos, Argentina\n\nTricovivax\n\nMedinfar, Lebanon; Medinfar, Portugal\n\nTricoxane 2%\n\nITF - Labomed Farmaceutica, Chile\n\nTricoxane 5%\n\nITF - Labomed Farmaceutica, Chile\n\nTricoxidil\n\nJohnson & Johnson, Italy\n\nTrugain\n\nZiska, Bangladesh\n\nTugain\n\nCipla, India\n\nUnipexil 2%\n\nGifrer, France\n\nUnipexil 5%\n\nGifrer, France\n\nVaxdil\n\nLicol, Colombia\n\nVius\n\nSpecial Medicines M.I.K.E., Greece\n\nWomen's Rogaine\n\nJohnson & Johnson, Canada; Johnson & Johnson, United States\n\nXenogrow\n\nIncepta, Bangladesh\n\nXue Rui\n\nBausch & Lomb, China\n\nYlox\n\nFortbenton, Argentina\n\nZeldilon\n\nDecomed, Portugal\n\nZitoxil 2%\n\nElmor, Venezuela\n\nZitoxil 3%\n\nElmor, Venezuela\n\nGlossary\n\nTermDefinition BANBritish Approved Name DCFDénomination Commune Française DCITDenominazione Comune Italiana IUPACInternational Union of Pure and Applied Chemistry ISInofficial Synonym JANJapanese Accepted Name OSOfficial Synonym PHPharmacopoeia Name Rec.INNRecommended International Nonproprietary Name (World Health Organization) USANUnited States Adopted Name WHOWorld Health Organization\n\nFurther information on drug naming conventions: International Nonproprietary Names.\n\nImportant Notice: The Drugs.com international database is in BETA release. This means it is still under development and may contain inaccuracies. It is not intended as a substitute for the expertise and judgement of your physician, pharmacist or other healthcare professional. It should not be construed to indicate that the use of any medication in any country is safe, appropriate or effective for you. Consult with your healthcare professional before taking any medication.\n\nFurther information\n\nAlways consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances."
    }
}